Bidil
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
In 2005 the FDA approved BiDil, the first drug ever to include a race-specific indication on its label - to treat heart failure…
June 2007 marked the second anniversary of the Food and Drug Administration (FDA)’s approval of BiDil, the first drug to be…
In a recent discussion about how scientific knowledge might potentially change our understanding of the nature and extent of…
Magazine, psychiatrist Sally Satel proudly asserted “I Am a Racial Profiling Doctor.”1 When she treats African Americans in her…
In 2005, the U.S. Food and Drug Administration (FDA) approved BiDil (NitroMed, Lexington, Massachusetts), a combination of 2…
This article endeavors to place into context recent developments surrounding the United States Food and Drug Administration…
On June 23, 2005, the U.S. Food and Drug Administration (FDA) formally approved the heart failure drug BiDil to treat heart…
Approval of 'race-based' drug is stimulating efforts to detect and predict true subgroups for drug response
The Food and Drug Administration (FDA) approval of BiDil unleashed a vigorous commentary, mostly critical of the decision. The…